Skip to main navigation
About Us
Leadership
Board of Directors
Science
Our Approach
About CNM-Au8®
Pipeline
EAP
EAP
ACT-EAP WITH CNM-Au8®
Investors
Overview
News & Events
Press Releases
News
Events
Presentations
Investor Presentation
Scientific Posters & Presentations
Webinars
Publications
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Financial Information
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Contact
About Us
Leadership
Board of Directors
Science
Our Approach
About CNM-Au8®
Pipeline
EAP
EAP
ACT-EAP WITH CNM-Au8®
Investors
Overview
News & Events
Press Releases
News
Events
Presentations
Investor Presentation
Scientific Posters & Presentations
Webinars
Publications
Corporate Governance
Executive Management
Board of Directors
Committee Composition
Governance Documents
Financial Information
SEC Filings
Annual Reports
Stock Information
Stock Quote & Chart
Historic Price Lookup
Analyst Coverage
Investor Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Contact
Event Details
Clene Inc. Presentation at Oppenheimer 32nd Annual Healthcare Conference
Mar 15, 2022
Webcast
Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2026 Clene Nanomedicine, Inc. - All rights reserved |
PRIVACY POLICY
|
COOKIE POLICY
|
TERMS OF USE
